Rosiglitazone is effective in obese and non-obese patients with Type 2 diabetes

被引：0
|
作者：
Deacon, L
Donnelly, S
Stewart, M
Hand, L
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A433 / A433
页数：1
相关论文
共 50 条
  • [11] METABOLIC SURGERY FOR NON-OBESE TYPE 2 DIABETES MELLITUS ASIAN PATIENTS
    Lee, Wei-Jei
    Ser, Kong-Han
    Lee, Ming-Hsien
    Chen, Shu-Chu
    Tsou, Jun-Juin
    Chen, Jung-Chien
    [J]. OBESITY SURGERY, 2015, 25 (08) : 1310 - 1310
  • [12] Thioazolidinediones are useful in treating non-obese patients with type 2 diabetes mellitus
    Tanaka, Y
    Kitamura, R
    Seo, M
    Ihara, Y
    Yamamoto, Y
    Ogata, T
    Motoyoshi, K
    [J]. DIABETES, 2002, 51 : A134 - A135
  • [13] Type 2 diabetes in the non-obese children and adolescents in Bangladesh
    Sayeed, M. A.
    Mahtab, H.
    Banu, A.
    Khanam, P. A.
    Latif, Z. A.
    Ahmed, A. U.
    Nahar, J. S.
    Khatun, K.
    Khan, A. Azad
    [J]. DIABETOLOGIA, 2008, 51 : S175 - S175
  • [14] Addition of rosiglitazone to metformin is effective in obese, insulin-resistant patients with type 2 diabetes
    Jones, T
    Jones, NP
    Sautter, M
    [J]. DIABETOLOGIA, 2000, 43 : A191 - A191
  • [15] Serum levels of fibronectin and endothelin-1 in obese and non-obese patients with Type 2 diabetes mellitus
    Mogylnytska, L
    Mankovsky, B
    [J]. DIABETOLOGIA, 2004, 47 : A455 - A456
  • [16] Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients
    Dominique Hansen
    Paul Dendale
    Milou Beelen
    Richard A. M. Jonkers
    Annelies Mullens
    Luk Corluy
    Romain Meeusen
    Luc J. C. van Loon
    [J]. European Journal of Applied Physiology, 2010, 109 : 397 - 404
  • [17] Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients
    Hansen, Dominique
    Dendale, Paul
    Beelen, Milou
    Jonkers, Richard A. M.
    Mullens, Annelies
    Corluy, Luk
    Meeusen, Romain
    van Loon, Luc J. C.
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2010, 109 (03) : 397 - 404
  • [18] Evaluation of Effective Dose During Ureteroscopy for Obese and Non-Obese Patients
    Wang, C.
    Nguyen, G.
    Chung, Y.
    Cabrera, F.
    Shins, R.
    Lipkin, M.
    Yoshizumi, T.
    [J]. MEDICAL PHYSICS, 2014, 41 (06) : 103 - 103
  • [19] Markers for obese and non-obese Type 2 diabetes identified using whole blood metabolomics
    Takayuki Teruya
    Sumito Sunagawa
    Ayaka Mori
    Hiroaki Masuzaki
    Mitsuhiro Yanagida
    [J]. Scientific Reports, 13
  • [20] Different β-cell secretory phenotype in non-obese compared to obese early type 2 diabetes
    Gudipaty, Lalitha
    Rosenfeld, Nora K.
    Fuller, Carissa S.
    Cuchel, Marina
    Rickels, Michael R.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (05)
12345